Table 1.
In Situ | In Vivo | In Vitro | |
---|---|---|---|
Off-the-shelf availability | Likely | Possible | Not possible |
Scalability | Easier | Difficult | Most difficult |
Ease of clinical translation | Easier | Complex | Complex |
Cost-effectiveness | More | Less | Least |
Disease modeling | No | No | Yes |
Drug screening modeling | No | No | Yes |